Seattle Genetics to Host Conference Call & Webcast Discussion of Fourth Quarter & Year 2017 Financial Results on February 6, ...
January 18 2018 - 8:00AM
Business Wire
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it
will report its fourth quarter and year 2017 financial results on
Tuesday, February 6, 2018 after the close of financial markets.
Following the results announcement, company management will host a
conference call and webcast discussion of the results and provide a
general corporate update. Access to the event can be obtained as
follows:
LIVE access on Tuesday, February 6, 20181:30 p.m. Pacific Time /
4:30 p.m. Eastern Time
- Telephone 888-778-9065 (domestic) or
719-325-2452 (international); conference ID 9278036
- Webcast available at
www.seattlegenetics.com in the Investors section
REPLAY access
- Telephone replay will be available
beginning at approximately 4:30 p.m. PT on Tuesday, February 6,
2018 through 5:00 p.m. PT on Friday, February 9, 2018 by calling
888-203-1112 (domestic) or 719-457-0820 (international); conference
ID 9278036
- Webcast replay will be available on the
Seattle Genetics website at www.seattlegenetics.com in the
Investors section
About Seattle Genetics
Seattle Genetics is an innovative biotechnology company
dedicated to improving the lives of people with cancer through
novel antibody-based therapies. The company’s industry-leading
antibody-drug conjugate (ADC) technology harnesses the targeting
ability of antibodies to deliver cell-killing agents directly to
cancer cells. Seattle Genetics commercializes ADCETRIS®
(brentuximab vedotin) for the treatment of several types of
CD30-expressing lymphomas. The company is also advancing a robust
pipeline of novel therapies for solid tumors and blood-related
cancers designed to address significant unmet medical needs and
improve treatment outcomes for patients. More information can be
found at www.seattlegenetics.com and follow @SeattleGenetics on
Twitter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180118005148/en/
Seattle Genetics, Inc.Peggy Pinkston,
425-527-4160ppinkston@seagen.com
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024